• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    State Street SPDR S&P Biotech ETF (NY:XBI)

    128.45 +0.59 (+0.46%)
    Streaming Delayed Price Updated: 2:19 PM EST, Jan 27, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,684,259
    Open 127.87
    Bid (Size) 128.45 (200)
    Ask (Size) 128.46 (200)
    Prev. Close 127.86
    Today's Range 127.53 - 129.93
    52wk Range 66.66 - 132.09
    Shares Outstanding 541,500
    Dividend Yield 1.27%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Why Did MNKD Stock Jump Over 7% In Pre-Market Today? ↗
    The U.S. FDA approved an update to the prescribing information for Afrezza inhalation powder to treat adults with diabetes mellitus. 
    Via Stocktwits
    News headline image
    The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
    The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year... 
    Via MarketMinute
    Topics Artificial Intelligence ETFs Initial Public Offering

    Performance

    YTD
    +5.7%
    +5.7%
    1 Month
    +4.1%
    +4.1%
    3 Month
    +15.1%
    +15.1%
    6 Month
    +48.4%
    +48.4%
    1 Year
    +38.7%
    +38.7%

    More News

    Read More
    News headline image
    Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It? ↗
    Via Stocktwits
    Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today ↗
    Via Stocktwits
    IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval ↗
    Via Stocktwits
    Why Did NRXP Stock Surge 21% Pre-Market Today? ↗
    Via Stocktwits
    IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients ↗
    Via Stocktwits
    Why Did TVTX Stock Crash 30% In Pre-Market Today? ↗
    Via Stocktwits
    IMRX Stock Closed Over 20% Higher Today: Here’s Why ↗
    Via Stocktwits
    News headline image
    Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗
    Via Stocktwits
    News headline image
    Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
    Via MarketMinute
    Topics ETFs Economy Intellectual Property
    Cidara Therapeutics Granted FDA Breakthrough Therapy Designation For Flu-Preventing Antiviral ↗
    Via Stocktwits
    News headline image
    Eaton, FTAI Aviation And More On CNBC's 'Final Trades' ↗
    Via Benzinga
    Topics ETFs Stocks
    News headline image
    Biotech Insiders Are Spending Billions. Trump Favors Less Oversight. One Biotech ETF Could Ride the Surge. ↗
    Via The Motley Fool
    Topics ETFs Economy Government
    News headline image
    Money Moving Into Healthcare Not AI; Four Fed Presidents Do Not Want a Rate Cut; Euphoria Wearing Off ↗
    Via Benzinga
    Topics Economy
    News headline image
    Taiwan Semiconductor, HealthEquity, Cboe Global Markets And More: CNBC's 'Final Trades' ↗
    Via Benzinga
    News headline image
    Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
    Via Benzinga
    Topics ETFs
    News headline image
    FDA Turmoil Spills Over To Aurinia Pharma As Lawsuit Targets Ex-Drug Review Chief — Retail Traders Cry ‘Stock Manipulation’ ↗
    Via Stocktwits
    Topics Lawsuit
    News headline image
    Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin ↗
    Via Benzinga
    Topics Artificial Intelligence ETFs
    News headline image
    Intellia Freezes Key Trial After Serious Liver Event, Stock Tumbles ↗
    Via Benzinga
    News headline image
    Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today ↗
    Via Stocktwits
    News headline image
    Biotech Boom: Strategic Realignments and AI Integration Fuel Investor Focus, Signaling Broader Market Shifts
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures ↗
    Via Benzinga
    News headline image
    4 Biotech Stocks Seeing Explosive Momentum Gains ↗
    Via Benzinga
    Topics ETFs Stocks
    News headline image
    How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline ↗
    Via Benzinga
    Topics ETFs Government

    Frequently Asked Questions

    Is State Street SPDR S&P Biotech ETF publicly traded?
    Yes, State Street SPDR S&P Biotech ETF is publicly traded.
    What exchange does State Street SPDR S&P Biotech ETF trade on?
    State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
    What is the ticker symbol for State Street SPDR S&P Biotech ETF?
    The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
    What is the current price of State Street SPDR S&P Biotech ETF?
    The current price of State Street SPDR S&P Biotech ETF is 128.45
    When was State Street SPDR S&P Biotech ETF last traded?
    The last trade of State Street SPDR S&P Biotech ETF was at 01/27/26 02:19 PM ET
    What is the market capitalization of State Street SPDR S&P Biotech ETF?
    The market capitalization of State Street SPDR S&P Biotech ETF is 69.56M
    How many shares of State Street SPDR S&P Biotech ETF are outstanding?
    State Street SPDR S&P Biotech ETF has 70M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.